Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 30, 2016

FEDERAL TRADE COMMISSION v. ENDO PHARMACEUTICALS INC. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 21, 2017

    Impax Loses Fees Bid In Opioid Pay-For-Delay Row With FTC

    A Pennsylvania federal judge on Monday declined to grant fees to Impax Laboratories Inc. after the Federal Trade Commission voluntarily dismissed its pay-for-delay suit over generic versions of an opioid, but admonished the agency for conduct that had been "less than admirable."

15 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login